Verus Capital Partners’s Viemed Healthcare VMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-34,150
Closed -$254K 502
2025
Q4
$254K Sell
34,150
-8,725
-20% -$59.8K 0.02% 382
2025
Q3
$291K Sell
42,875
-5,095
-11% -$34.5K 0.02% 328
2025
Q2
$331K Sell
47,970
-15,950
-25% -$108K 0.03% 276
2025
Q1
$465K Sell
63,920
-1,450
-2% -$11.4K 0.05% 215
2024
Q4
$524K Sell
65,370
-6,825
-9% -$59.2K 0.05% 193
2024
Q3
$529K Buy
72,195
+750
+1% +$5.36K 0.05% 187
2024
Q2
$468K Buy
71,445
+4,295
+6% +$32.4K 0.05% 200
2024
Q1
$633K Sell
67,150
-1,020
-1% -$8.74K 0.07% 158
2023
Q4
$535K Buy
68,170
+2,525
+4% +$18.3K 0.07% 165
2023
Q3
$442K Sell
65,645
-1,450
-2% -$11.9K 0.06% 176
2023
Q2
$656K Sell
67,095
-5,085
-7% -$51.6K 0.09% 130
2023
Q1
$697K Sell
72,180
-14,740
-17% -$129K 0.11% 119
2022
Q4
$657K Sell
86,920
-1,075
-1% -$7.28K 0.12% 114
2022
Q3
$528K Buy
87,995
+66,729
+314% +$428K 0.1% 137
2022
Q2
$491K Sell
21,266
-70,189
-77% -$378K 0.1% 149
2022
Q1
$477K Buy
+91,455
New +$425K 0.07% 188
2020
Q1
$295K Sell
62,075
-475
-0.8% -$2.35K 0.09% 135
2019
Q4
$388K Buy
+62,550
New +$434K 0.13% 129

Other funds holding VMD

Verus Capital Partners's VMD Position: Q1 2026 in Review

Verus Capital Partners sold out of Viemed Healthcare (VMD) in Q1 2026, closing a stake of 34,150 shares — an estimated $254K sold.

Verus Capital Partners first reported a position in VMD in Q4 2019 and held it in 18 quarters. The position peaked at $697K in Q1 2023. 149 funds tracked by Wall St. Rank hold VMD as of Q1 2026.

  • Verus Capital Partners reported no remaining Viemed Healthcare position as of Q1 2026 after selling out during the quarter.
  • Verus Capital Partners sold 34,150 Viemed Healthcare shares in Q1 2026, an estimated $254K.
  • Verus Capital Partners first reported a position in Viemed Healthcare in Q4 2019 and held it in 18 quarters.
  • Verus Capital Partners's Viemed Healthcare position peaked at $697K in Q1 2023.
  • 149 funds tracked by Wall St. Rank held Viemed Healthcare as of Q1 2026.

Based on Verus Capital Partners's 13F filing for Q1 2026, filed 22 May 2026.